- Updates on China’s National Medical Products Administration (NMPA) regulations
- Recent reforms in drug and device approval processes
- Best practices for obtaining IND and NDA approvals in China
- 中国国家药品监督管理局（NMPA）法规更新
- 药品和医疗器械审批流程的最新改革
- 在中国获得IND（新药临床试验申请）和NDA（新药上市申请）批准的最佳实践